John Militello, See Remarks at ROCKET PHARMACEUTICALS, INC. (RCKT), sold 1,157 shares at $3.34 ($4K) on 2026-02-18, disclosed to the SEC on 2026-02-20.
Seasonal sale ($4k) by See Remarks — this insider has traded RCKT in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| RCKT | SELL | 2026-02-18 | $12K | — | Filing → |
| RCKT | SELL | 2025-11-20 | $3K | — | Filing → |
| RCKT | SELL | 2025-10-16 | $193K | — | Filing → |